Elke Nolte



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+ -ATPase inhibition. (2018) Silva IT, Munkert J, Nolte E, Schneider NFZ, Rocha SC, Ramos ACP, Kreis W, et al. Journal article, Original article Production of the Cytotoxic Cardenolide Glucoevatromonoside by Semisynthesis and Biotransformation of Evatromonoside by a Digitalis lanata Cell Culture. (2017) Munkert J, Santiago Franco M, Nolte E, Silva IT, Oliveira Castilho R, Ottoni FM, Schneider NFZ, et al. Journal article, Original article A new semisynthetic cardenolide analog 3β-[2-(1-amantadine)-1-on-ethylamine]-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines (2017) Nolte E, Wach S, Silva IT, Lukat S, Ekici AB, Munkert J, Müller-Uri F, et al. Journal article, Original article Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients (2015) Taubert H, Wach S, Jung R, Pugia M, Keck B, Bertz S, Nolte E, et al. Journal article The new semisynthetic cardenolide analog 3β-[2-(1-amantadine)-1-on-ethylamine]-digitoxigenin (AMANTADIG) efficiently suppresses cell growth in human leukemia and urologic tumor cell lines (2015) Nolte E, Sobel A, Wach S, Hertlein H, Ebert N, Müller-Uri F, Slany R, et al. Journal article, Original article Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing (2014) Hart M, Nolte E, Wach S, Szczyrba J, Taubert H, Rau T, Hartmann A, et al. Journal article